25-05-2018
04-04-2018
STALICLA SA’s CEO Lynn Durham will be part of the panel at the Neurotech Investing & Partnering Conference taking place on May 1st in Boston, USA. The ‘Targeting Orphan Diseases’ panel which Lynn is a part of, will take place at 3:40pm Tuesday May 1st.
15-03-2018
SACHS Biocapital USA Forum taking place on 21st March at the New York Academy of Sciences, USA. We are delighted to announce that CEO Lynn Durham will deliver a presentation showcasing STALICLA’s innovative approach and development pipeline, at 11:20am. In addition, Lynn will also be a part of the of the ‘Renewed Approaches for Neuroscience’ panel, which will be held at 11:45am. The Plenary panel is likely to be a highly anticipated session where Lynn will be discussing the hot topic of advanced therapeutics alongside other biotech and pharmaceutical leaders.
28-02-2018
STALICLA selected among the 2018 top 50 start-ups in Switzerland.